Filing Details
- Accession Number:
- 0001127602-10-002100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-25 12:00:00
- Reporting Period:
- 2010-01-22
- Filing Date:
- 2010-01-25
- Accepted Time:
- 2010-01-25 14:18:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
882796 | Biocryst Pharmaceuticals Inc | BCRX | Biological Products, (No Disgnostic Substances) (2836) | 621413174 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1410397 | Stuart Grant | 2190 Parkway Lake Drive Birmingham AL 35244- | Sr Vp & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-01-22 | 17,027 | $7.02 | 9,000 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transacted under a 10b5-1 plan that was adopted on 11/23/09.